Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor

Autor:	Giordanetto, Fabrizio1 fabrizio.giordanetto@astrazeneca.com, Wållberg, Andreas1, Knerr, Laurent1, Selmi, Nidhal1, Ullah, Victoria1, Thorstensson, Fredrik1, Lindelöf, Åsa1, Karlsson, Staffan1, Nikitidis, Grigorios1, Llinas, Antonio2, Wang, Qing-Dong3, Lindqvist, Anders3, Högberg, Ågot3, Lindhardt, Emma2, Åstrand, Annika3, Duker, Göran3
Zdroj:	Bioorganic & Medicinal Chemistry Letters. Jan2013, Vol. 23 Issue 1, p119-124. 6p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect